Back to search

Expression ofrasOncogene p21 in Prostate Cancer

Data up to Jan 2025

Published1986
Citations269
References33

Total Citations Per Year

Abstract

References (33)

Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.

1981 • 14,396 citations

Prediction of Prognosis for Prostatic Adenocarcinoma by Combined Histological Grading and Clinical Staging

1974 • 2,200 citations

CELLULAR ONCOGENES AND RETROVIRUSES

1983 • 1,671 citations

Mechanism of activation of a human oncogene

1982 • 1,417 citations

A point mutation is responsible for the acquisition of transforming properties by the T24 human bladder carcinoma oncogene

1982 • 1,398 citations

Cellular Oncogenes and Multistep Carcinogenesis

1983 • 1,154 citations

Requirement for ras proto-oncogene function during serum-stimulated growth of NIH 3T3 cells

1985 • 913 citations

Expression of Cellular Oncogenes in Human Malignancies

1984 • 840 citations

Monoclonal antibodies to the p21 products of the transforming gene of Harvey murine sarcoma virus and of the cellular ras gene family

1982 • 836 citations

Activation of the T24 bladder carcinoma transforming gene is linked to a single amino acid change

1982 • 706 citations

Malignant transformation of early passage rodent cells by a single mutated human oncogene

1984 • 479 citations

Oncogenes in solid human tumours

1982 • 467 citations

Microinjection of the oncogene form of the human H-ras (t-24) protein results in rapid proliferation of quiescent cells

1984 • 401 citations

Malignant Activation of a K- ras Oncogene in Lung Carcinoma But Not in Normal Tissue of the Same Patient

1984 • 395 citations

Prostatic-specific antigen: An immunohistologic marker for prostatic neoplasms

1981 • 370 citations

The Histology and Prognosis of Prostatic Cancer

1967 • 264 citations

Monoclonal antibodies define differential ras gene expression in malignant and benign colonic diseases

1984 • 226 citations

Monoclonal antibodies of predefined specificity detect activated ras gene expression in human mammary and colon carcinomas.

1984 • 223 citations

Frequency of molecular alterations affecting ras protooncogenes in human urinary tract tumors.

1985 • 191 citations

Expression of p21ras in fresh primary and metastatic human colorectal tumors.

1985 • 181 citations

Altered gene products are associated with activation of cellular rasK genes in human lung and colon carcinomas

1983 • 175 citations

ras Oncogene p21 expression is increased in premalignant lesions and high grade bladder carcinoma.

1985 • 173 citations

RELATION BETWEEN BENIGN PROSTATIC HYPERPLASIA AND CANCER OF THE PROSTATE

1974 • 140 citations

Cancer of the Prostate Among Men With Benign Prostatic Hyperplasia 2

1974 • 138 citations

Evaluation of Prostate Specific Acid Phosphatase and Prostate Specific Antigen in Identification of Prostatic Cancer

1983 • 93 citations

Multiple Immunoperoxidase Markers in Benign Hyperplasia and Adenocarcinoma of the Prostate

1984 • 90 citations

Carcinoembryonic antigen in patients with tumors of the urogenital tract

1972 • 86 citations

Differential Binding to Human Mammary and Nonmammary Tumors of Monoclonal Antibodies Reactive with Carcinoembryonic Antigen

1983 • 79 citations

Pathologic differentiation and prognosis of prostatic carcinoma

1969 • 28 citations

Immunofluorescence for Prostatic Acid Phosphatase: Clinical Applications

1981 • 22 citations

Prostatic carcinoma Relationship betwen primary tumor, Histologic grade, and response to chemotherapy☆

1976 • 14 citations

A histochemical study of glycosidases in benign prostatic hyperplasia and in prostatic carcinoma in the human

1978 • 10 citations

Relationship between Prostatic Cytoplasmic and Nuclear Androgen Receptors in Patients with Carcinoma of the Prostate

1981 • 5 citations

Cited By (0)

No citing papers found in database

Expression ofrasOncogene p21 in Prostate Cancer (1986) – New England Journal of Medicine | Metascience Observatory Explorer